First Eagle Investment Management
BIVV

First Eagle Investment Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

First Eagle Investment Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-157,035
Closed -$8.55M – 344
2017
Q1 		$8.55M Buy
+157,035
New +$7.74M 0.02% 155

Other funds holding BIVV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.63B AUM 5.11% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

First Eagle Investment Management's BIVV Position: Q2 2017 in Review

First Eagle Investment Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q2 2017, closing a stake of 157,035 shares — an estimated $8.55M sold.

First Eagle Investment Management first reported a position in BIVV in Q1 2017 and held it in 1 quarter. The position peaked at $8.55M in Q1 2017. 452 funds tracked by Wall St. Rank hold BIVV as of Q2 2017.

  • First Eagle Investment Management reported no remaining Bioverativ Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • First Eagle Investment Management sold 157,035 Bioverativ Inc. Common Stock shares in Q2 2017, an estimated $8.55M.
  • First Eagle Investment Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 1 quarter.
  • First Eagle Investment Management's Bioverativ Inc. Common Stock position peaked at $8.55M in Q1 2017.
  • 452 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q2 2017.

Based on First Eagle Investment Management's 13F filing for Q2 2017, filed 4 Aug 2017.